Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002301
Status:
UNKNOWN
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Study of Foscarnet in the Treatment of Cytomegalovirus CMV of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir
Sponsor:
Astra USA
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
Foscarnet Treatment of Cytomegalovirus CMV Retinitis in AIDS Patients Not Eligible for Ganciclovir Therapy and Ganciclovir Treatment Failures
Status:
UNKNOWN
Status Verified Date:
1991-03
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the safety and efficacy of foscarnet induction treatment of cytomegalovirus CMV retinitis in AIDS patients who have previously suffered severe dose-limiting ganciclovir-related myelosuppression who are ineligible for ganciclovir treatment due to myelosuppression or who have clearly failed to have a therapeutic response to ganciclovir therapy To assess the duration of clinical response To evaluate the effect on quantitative CMV cultures of blood and urine To determine the effect on recovery of HIV p24 antigen capture direct from plasma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 88-FOS-02 | None | None | None |